Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors

By Fujino H.   Saito T.   Tsunenari Y.   Kojima J.   Sakaeda T.  

Xenobiotica, Vol. 34, Iss. 11-12, 2004-11 ,pp. : 961-971

Informa Healthcare

Access to resources Recommend Favorite

Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site

By Camarero N.   Nadal A.   Barrero M.J.   Haro D.   Marrero P.F.  

Nucleic Acids Research, Vol. 31, Iss. 6, 2003-03 ,pp. : 1693-1703

Oxford University Press

Access to resources Recommend Favorite

The Hepatocyte Nuclear Factor 4 (HNF-4) Represses the Mitochondrial HMG-CoA Synthase Gene

By Rodriguez J.C.   Ortiz J.A.   Hegardt F.G.   Haro D.  

Biochemical and Biophysical Research Communications, Vol. 242, Iss. 3, 1998-01 ,pp. : 692-696

Elsevier

Access to resources Recommend Favorite

Low Activity of Mitochondrial HMG-CoA Synthase in Liver of Starved Piglets Is Due to Low Levels of Protein Despite High mRNA Levels

By Barrero M.J.   Alho C.S.   Ortiz J.A.   Hegardt F.G.   Haro D.   Marrero P.F.  

Archives of Biochemistry and Biophysics, Vol. 385, Iss. 2, 2001-01 ,pp. : 364-371

Elsevier

Access to resources Recommend Favorite

The statin class of HMG-CoA reductase inhibitors demonstrate differential activation of the nuclear receptors PXR, CAR and FXR, as well as their downstream target genes

By Howe Katharine   Sanat Faizah   Thumser Alfred E.   Coleman Tanya   Plant Nick  

Xenobiotica, Vol. 41, Iss. 7, 2011-07 ,pp. : 519-529

Informa Healthcare

Access to resources Recommend Favorite